User profiles for Florian Gärtner

Florian Gärtner

- Verified email at med.uni-muenchen.de - Cited by 3011

Florian Gärtner

- Verified email at hispeed.ch - Cited by 447

[HTML][HTML] SwissFEL: the Swiss X-ray free electron laser

…, H Fitze, U Flechsig, R Follath, F Frei, F Gärtner… - Applied Sciences, 2017 - mdpi.com
The SwissFEL X-ray Free Electron Laser (XFEL) facility started construction at the Paul Scherrer
Institute (Villigen, Switzerland) in 2013 and will be ready to accept its first users in 2018 …

Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and'instruct'them with pattern-recognition and motility programs

…, A Tirniceriu, M Lorenz, ML von Brühl, F Gärtner… - Nature …, 2013 - nature.com
Coordinated navigation within tissues is essential for cells of the innate immune system to
reach the sites of inflammatory processes, but the signals involved are incompletely …

Lifeact mice for studying F-actin dynamics

J Riedl, KC Flynn, A Raducanu, F Gärtner, G Beck… - Nature …, 2010 - nature.com
Visualization of filamentous actin (F-actin) in living cells is critical for the study of morphogenetic
processes such as cell division, migration or polarization. We recently described in …

[HTML][HTML] Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study

…, M Bögemann, M Claesener, E Eppard, F Gärtner… - EJNMMI research, 2015 - Springer
Background Radioligand therapy (RLT) with 177 Lu-DKFZ-617 PSMA (Lu-PSMA) (prostate-specific
membrane antigen) is a novel targeted therapy of metastatic prostate cancer. We …

[HTML][HTML] Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer

…, R Fimmers, A Yordanova, CD Schlenkhoff, F Gärtner… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Prostate-specific membrane antigen (PSMA) is highly expressed on prostate epithelial cells
and strongly up-regulated in prostate cancer (PC), making it an optimal target for the …

[HTML][HTML] Clinical translation and first in-human use of [44Sc] Sc-PSMA-617 for PET imaging of metastasized castrate-resistant prostate cancer

…, A Khawar, RA Bundschuh, FC Gärtner… - Theranostics, 2017 - ncbi.nlm.nih.gov
Background: Various trivalent radiometals are well suited for labeling of DOTA-conjugated
variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The …

[HTML][HTML] Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI

…, D Thomas, RA Bundschuh, WR Bauer, FC Gärtner - Oncotarget, 2016 - ncbi.nlm.nih.gov
Diagnosis of cardiac sarcoidosis is often challenging. Whereas cardiac magnetic resonance
imaging (CMR) and positron emission tomography/computed tomography (PET/CT) with 18 …

Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis

M Essler, FC Gärtner, F Neff, B Blechert… - European journal of …, 2012 - Springer
Purpose Targeted delivery of alpha-particle-emitting radionuclides is a promising novel
option in cancer therapy. We generated stable conjugates of the vascular tumour-homing …

[PDF][PDF] Multiple redox and non-redox interactions define 2-Cys peroxiredoxin as a regulatory hub in the chloroplast

…, T Seidel, M Laxa, SMN De Miranda, F Gärtner… - Molecular Plant, 2009 - cell.com
In plants, the highly abundant 2-cysteine peroxiredoxin (2-CysPrx) is associated with the
chloroplast and involved in protecting photosynthesis. This work addresses the multiple …

Niche WNT5A regulates the actin cytoskeleton during regeneration of hematopoietic stem cells

…, L Henkel, F Gärtner, B Vieth, MC Florian… - Journal of experimental …, 2017 - rupress.org
Here, we show that the Wnt5a-haploinsufficient niche regenerates dysfunctional HSCs, which
do not successfully engraft in secondary recipients. RNA sequencing of the regenerated …